A detailed history of Titleist Asset Management, Ltd. transactions in Rvl Pharmaceuticals PLC stock. As of the latest transaction made, Titleist Asset Management, Ltd. holds 92,503 shares of RVLP stock, worth $0. This represents 0.02% of its overall portfolio holdings.

Number of Shares
92,503
Previous 98,151 5.75%
Holding current value
$0
Previous $206,000 50.0%
% of portfolio
0.02%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 12, 2023

SELL
$1.02 - $1.61 $5,760 - $9,093
-5,648 Reduced 5.75%
92,503 $0
Q3 2022

Nov 14, 2022

SELL
$1.28 - $2.91 $25,794 - $58,642
-20,152 Reduced 17.03%
98,151 $206,000
Q2 2022

Aug 15, 2022

BUY
$1.21 - $1.81 $18,189 - $27,209
15,033 Added 14.56%
118,303 $161,000
Q1 2022

May 04, 2022

BUY
$1.03 - $2.01 $23,778 - $46,402
23,086 Added 28.79%
103,270 $175,000
Q4 2021

Feb 17, 2022

BUY
$0.98 - $3.06 $78,580 - $245,363
80,184 New
80,184 $87,000

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0

About RVL Pharmaceuticals plc


  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track This Portfolio

Track Titleist Asset Management, Ltd. Portfolio

Follow Titleist Asset Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Titleist Asset Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Titleist Asset Management, Ltd. with notifications on news.